Boswellia serrata gum resin aqueous extract upregulatesBDNF but not CREB expression in adult male rat hippocampus

Boswellia serrata gum resin aqueous extract upregulatesBDNF but not CREB expression in adult male rat hippocampus

Background/aim: Boswellia from the family Burseraceae has been proposed for prevention of amnesia; however, the molecular mechanism by which it affects memory is not clear. To reveal the potential molecular mechanism, the effects of boswellia on the expression of two memory related genes, CREB and BDNF, were investigated. Materials and methods: Twenty-one male rats were randomly divided into 3 groups (n = 7): the control group received distilled water and the treatment groups received two doses of aqueous extract of Boswellia serrata gum resin (boswellia) (50 and 100 mg/kg) every day for 4 weeks. The animals were tested by the Morris water maze (MWM) and their hippocampus was isolated. Expression of CREB and BDNF genes was analyzed by Q-RT-PCR. Results: The MWM test showed improvement in spatial learning and memory in both treatment groups. Gene expression analysis revealed a significant increase in BDNF but not CREB expression in rats treated with both 50 and 100 mg/kg doses in comparison with the control group. Conclusion: Although boswellia exerts its effects on memory formation at least partly by affecting the expression of BDNF, the results imply that boswellia probably affects memory via another BDNF-related pathway than the BDNF CREB BDNF cycle.

___

  • 1. Bansal N, Mehan S, Kalra S, Khanna D. Boswellia serratafrankincense (a Jesus gifted herb); an updated pharmacological profile. Pharmacologia 2013; 4: 457-463.
  • 2. Qurishi Y, Hamid A, Zargar M, Singh SK, Saxena AK. Potential role of natural molecules in health and disease: importance of boswellic acid. J Med Plants Res 2010; 4: 2778-2785.
  • 3. Ernst E. Frankincense: systematic review. Br Med J 2008; 337: a2813.
  • 4. Moussaieff A, Mechoulam R. Boswellia resin: from religious ceremonies to medical uses; a review of in‐vitro, in‐vivo and clinical trials. J Pharm Pharmacol 2009; 61: 1281-1293.
  • 5. Karima O, Riazi G, Yousefi R, Movahedi AA. The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study). Neurol Sci 2010; 31: 315-320.
  • 6. Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M. Frankincense (Rŭ Xiāng; Boswellia Species): From the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med 2013; 3: 221-226.
  • 7. Jalili C, Salahshoor M, Pourmotabbed A, Moradi S, Roshankhah S, Darehdori AS, Motaghi M. The effects of aqueous extract of Boswellia Serrata on hippocampal region CA1 and learning deficit in kindled rats. RPS 2014; 9: 351-358.
  • 8. Mahmoudi A, Hosseini-Sharifabad A, Monsef-Esfahani HR, Yazdinejad AR, Khanavi M, Roghani A, Beyer C, Sharifzadeh M. Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats. J Nat Med 2011; 65: 519-525.
  • 9. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 2011; 50: 349-369.
  • 10. Stork O, Welzl H. Memory formation and the regulation of gene expression. Cell Mol Life Sci 1999; 55: 75-92.
  • 11. Silva A J, Kogan J, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998; 21: 127-148.
  • 12. Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005; 28: 436-445.
  • 13. Russo-Neustadt A. Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin Clin Neuropsychiatry 2003; 8: 109-118.
  • 14. Tully T, Bourtchouladze R, Scott R, Tallman J. Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2003; 2: 267-277.
  • 15. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH. BDNF is essential to promote persistence of long-term memory storage. PNAS 2008; 105: 2711-2716.
  • 16. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238- 258.
  • 17. Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009; 5: 311-322.
  • 18. Moussaieff A, Gross M, Nesher E, Tikhonov T, Yadid G, Pinhasov A. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals. J Psychopharmacol 2012; 26: 1584-1593.
  • 19. Delany JR, Pentella MA, Rodriguez JA, Shah KV, Baxley KP, Holmes DE. Guidelines for biosafety laboratory competency. MMWR 2011; 60: 1-6
  • 20. Morris RGM. Morris water maze. Scholarpedia 2008; 3: 6315.
  • 21. Hosseini Sharifabad M, Esfandiari E. A morphometeric study on CA3 hippocampal field in young rats following maternal administration of Boswellia serrata resin during gestation. Iran J Basic Med Sci 2007; 10: 176-182.
  • 22. Hosseini-Sharifabad M, Esfandiary E. Effect of maternal consumption of aqueous extract of the gum resin of Boswellia Serrata during lactation on increasing power of learning and memory in adult offsprings. Iran J Basic Med Sci 2003; 6: 207- 211 (in Persian).
  • 23. Hosseini M, Hadjzadeh MA, Derakhshan M, Havakhah S, Rassouli FB, Rakhshandeh H, Saffarzadeh F. The beneficial effects of olibanum on memory deficit induced by hypothyroidism in adult rats tested in Morris water maze. Arch Pharm Res 2010; 33: 463-468.
  • 24. Bekinschtein P, Cammarota M, Izquierdo I, Medina JH. BDNF and memory formation and storage. Neuroscientist 2008; 14: 147-156.
  • 25. Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory? Front Mol Neurosci 2010; 3: 1.
  • 26. Bekinschtein P, Cammarota M, Medina JH. BDNF and memory processing. Neuropharmacology 2014; 76: 677-683.
  • 27. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123-131.
  • 28. Slipczuk L, Bekinschtein P, Katche C, Cammarota M, Izquierdo I, Medina JH. BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS One 2009; 4: e6007.
  • 29. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 2000; 287: 2262-2267.